Next-generation sequencing panel cost-effective for CRC
(HealthDay)—Use of a next-generation sequencing (NGS) panel including genes associated with highly penetrant colorectal cancer and polyposis (CRCP) syndromes is cost-effective for CRCP diagnosis, according to a study published ...
May 9, 2015
0
5